Willin, an Upstream Component of the Hippo Signaling Pathway, Orchestrates Mammalian Peripheral Nerve Fibroblasts

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Moleirinho, Susana ^a,b   Patrick, Calum ^a   Tilston Lünel, Andrew M ^b   Higginson, Jennifer R ^d   Angus, Liselotte ^b   Antkowiak, Maciej ^b   Barnett, Susan C ^d   Prystowsky, Michael B ^c   Reynolds, Paul A ^a   Gunn Moore, Frank J ^b  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIPPO PROTEIN; PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR YAP; UNCLASSIFIED DRUG; WILLIN PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING; MOUSE; NERVE REGENERATION; NEUROMODULATION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SCHWANN CELL; SCIATIC NERVE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; EPHRIN-B2; FIBROBLASTS; GENE EXPRESSION REGULATION; HOMEOSTASIS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SCIATIC NERVE; SIGNAL TRANSDUCTION;

MAMMALIA; RATTUS;

EID: 84876005254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060028     Document Type: Article

References (60)

1. Edgar BA, (2006) From cell structure to transcription: Hippo forges a new path. Cell 124: 267-273.
2. Harvey K, Tapon N, (2007) The Salvador-Warts-Hippo pathway- an emerging tumour-suppressor network. Nature reviews Cancer 7: 182-191.
3. Pan D, (2010) The hippo signaling pathway in development and cancer. Developmental cell 19: 491-505.
4. Zhao B, Tumaneng K, Guan KL, (2011) The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nature cell biology 13: 877-883.
5. Dong J, Feldmann G, Huang J, Wu S, Zhang N, et al. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133.
6. Oka T, Mazack V, Sudol M, (2008) Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). The Journal of biological chemistry 283: 27534-27546.
7. Zhang J, Smolen GA, Haber DA, (2008) Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer research 68: 2789-2794.
8. Zhao B, Wei X, Li W, Udan RS, Yang Q, et al. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes & development 21: 2747-2761.
9. Angus L, Moleirinho S, Herron L, Sinha A, Zhang X, et al. (2012) Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP. Oncogene 31: 238-250.
10. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, et al. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Current biology: CB 17: 2054-2060.
11. Moleirinho S, Chang N, Sims AH, Tilston-Lünel AM, Angus L, et al. (2012) KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals. Oncogene.
12. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, et al. (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proceedings of the National Academy of Sciences of the United States of America 103: 12405-12410.
13. Ramos A, Camargo FD, (2012) The Hippo signaling pathway and stem cell biology. Trends in cell biology 22: 339-346.
14. Zhang J, Ji JY, Yu M, Overholtzer M, Smolen GA, et al. (2009) YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nature cell biology 11: 1444-1450.
15. Zhou D, Conrad C, Xia F, Park JS, Payer B, et al. (2009) Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer cell 16: 425-438.
16. Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, et al. (2006) The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nature cell biology 8: 27-36.
17. Xiao L, Chen Y, Ji M, Dong J, (2011) KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases. The Journal of biological chemistry 286: 7788-7796.
18. Yu J, Zheng Y, Dong J, Klusza S, Deng WM, et al. (2010) Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Developmental cell 18: 288-299.
19. Zhang N, Bai H, David KK, Dong J, Zheng Y, et al. (2010) The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Developmental cell 19: 27-38.
20. Judson RN, Tremblay AM, Knopp P, White RB, Urcia R, et al. (2012) The Hippo pathway member Yap plays a key role in influencing fate decisions in muscle satellite cells. Journal of cell science.
21. Charge SB, Rudnicki MA, (2004) Cellular and molecular regulation of muscle regeneration. Physiological reviews 84: 209-238.
22. Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, et al. (2010) The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes & development 24: 2383-2388.
23. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, et al. (2010) The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes & development 24: 1106-1118.
24. Harrisingh MC, Perez-Nadales E, Parkinson DB, Malcolm DS, Mudge AW, et al. (2004) The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. The EMBO journal 23: 3061-3071.
25. Napoli I, Noon LA, Ribeiro S, Kerai AP, Parrinello S, et al. (2012) A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron 73: 729-742.
26. Parrinello S, Napoli I, Ribeiro S, Digby PW, Fedorova M, et al. (2010) EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting. Cell 143: 145-155.
27. Gunn-Moore FJ, Welsh GI, Herron LR, Brannigan F, Venkateswarlu K, et al. (2005) A novel 4.1 ezrin radixin moesin (FERM)-containing protein, 'Willin'. FEBS letters 579: 5089-5094.
28. Boedigheimer M, Laughon A, (1993) Expanded: a gene involved in the control of cell proliferation in imaginal discs. Development 118: 1291-1301.
29. Brockes JP, Fields KL, Raff MC, (1979) Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain research 165: 105-118.
30. Lakatos A, Franklin RJ, Barnett SC, (2000) Olfactory ensheathing cells and Schwann cells differ in their in vitro interactions with astrocytes. Glia 32: 214-225.
31. Tait S, Gunn-Moore F, Collinson JM, Huang J, Lubetzki C, et al. (2000) An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. The Journal of cell biology 150: 657-666.
32. Davis JQ, Lambert S, Bennett V, (1996) Molecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+/third FNIII domain-) and NrCAM at nodal axon segments. The Journal of cell biology 135: 1355-1367.
33. Gunn-Moore FJ, Hill M, Davey F, Herron LR, Tait S, et al. (2006) A functional FERM domain binding motif in neurofascin. Molecular and cellular neurosciences 33: 441-446.
34. Scaravilli F, (1984) Regeneration of the perineurium across a surgically induced gap in a nerve encased in a plastic tube. Journal of anatomy 139 (Pt 3): 411-424.
35. Schroder JM, May R, Weis J, (1993) Perineurial cells are the first to traverse gaps of peripheral nerves in silicone tubes. Clinical neurology and neurosurgery 95Suppl: S78-83.
36. Brown GL, Nanney LB, Griffen J, Cramer AB, Yancey JM, et al. (1989) Enhancement of wound healing by topical treatment with epidermal growth factor. The New England journal of medicine 321: 76-79.
37. Cao C, Sun Y, Healey S, Bi Z, Hu G, et al. (2006) EGFR-mediated expression of aquaporin-3 is involved in human skin fibroblast migration. The Biochemical journal 400: 225-234.
38. Carpenter G, Cohen S, (1990) Epidermal growth factor. The Journal of biological chemistry 265: 7709-7712.
39. Zhao B, Ye X, Yu J, Li L, Li W, et al. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes & development 22: 1962-1971.
40. Gabbiani G, Hirschel BJ, Ryan GB, Statkov PR, Majno G, (1972) Granulation tissue as a contractile organ. A study of structure and function. The Journal of experimental medicine 135: 719-734.
41. Sorrell JM, Caplan AI, (2009) Fibroblasts-a diverse population at the center of it all. International review of cell and molecular biology 276: 161-214.
42. Burnett MG, Zager EL, (2004) Pathophysiology of peripheral nerve injury: a brief review. Neurosurgical focus 16: E1.
43. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, et al. (2011) Role of YAP/TAZ in mechanotransduction. Nature 474: 179-183.
44. Halder G, Dupont S, Piccolo S, (2012) Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nature reviews Molecular cell biology 13: 591-600.
45. Chambers I, Tomlinson SR, (2009) The transcriptional foundation of pluripotency. Development 136: 2311-2322.
46. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
47. Umeda N, Ozaki H, Hayashi H, Oshima K, (2004) Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases. American journal of ophthalmology 138: 270-279.
48. Wynn TA, (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. The Journal of clinical investigation 117: 524-529.
49. Fujii K, Dousaka-Nakajima N, Imamura S, (1995) Epidermal growth factor enhancement of HSC-1 human cutaneous squamous carcinoma cell adhesion and migration on type I collagen involves selective up-regulation of alpha 2 beta 1 integrin expression. Experimental cell research 216: 261-272.
50. Matthay MA, Thiery JP, Lafont F, Stampfer F, Boyer B, (1993) Transient effect of epidermal growth factor on the motility of an immortalized mammary epithelial cell line. Journal of cell science 106 (Pt 3): 869-878.
51. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P, (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. The Biochemical journal 288 (Pt 2): 351-355.
52. Xie Z, Jiang Y, Liao EY, Chen Y, Pennypacker SD, et al. (2012) PIKE mediates EGFR proliferative signaling in squamous cell carcinoma cells. Oncogene 31: 5090-5098.
53. Block ER, Klarlund JK, (2008) Wounding sheets of epithelial cells activates the epidermal growth factor receptor through distinct short- and long-range mechanisms. Molecular biology of the cell 19: 4909-4917.
54. Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI, (2007) Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. The Journal of cell biology 177: 893-903.
55. Maitra S, Kulikauskas RM, Gavilan H, Fehon RG, (2006) The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling. Current biology: CB 16: 702-709.
56. Gamell C, Susperregui AG, Bernard O, Rosa JL, Ventura F, (2011) The p38/MK2/Hsp25 pathway is required for BMP-2-induced cell migration. PloS one 6: e16477.
57. Oumi N, Taniguchi KA, Kanai AM, Yasunaga M, Nakanishi T, et al. (2012) A crucial role of bone morphogenetic protein signaling in the wound healing response in acute liver injury induced by carbon tetrachloride. International journal of hepatology 2012: 476820.
58. Tsujii M, Akeda K, Iino T, Uchida A, (2009) Are BMPs involved in normal nerve and following transection?: a pilot study. Clinical orthopaedics and related research 467: 3183-3189.
59. Leask A, Abraham DJ, (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. Journal of cell science 119: 4803-4810.
60. Brigstock DR, (1999) The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocrine reviews 20: 189-206.